All Title Author
Keywords Abstract

PLOS ONE  2013 

Oncogenic Features of PHF8 Histone Demethylase in Esophageal Squamous Cell Carcinoma

DOI: 10.1371/journal.pone.0077353

Full-Text   Cite this paper   Add to My Lib

Abstract:

Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. It has been reported that histone demethylases are involved in the carcinogenesis of certain types of tumors. Here, we studied the role of one of the histone lysine demethylases, plant homeodomain finger protein 8 (PHF8), in the carcinogenesis of esophageal squamous cell carcinoma (ESCC). Using short hairpin RNA via lentiviral infection, we established stable ESCC cell lines with constitutive downregulation of PHF8 expression. Knockdown of PHF8 in ESCC cells resulted in inhibition of cell proliferation and an increase of apoptosis. Moreover, there were reductions of both anchorage-dependent and -independent colony formation. In vitro migration and invasion assays showed that knockdown of PHF8 led to a reduction in the number of migratory and invasive cells. Furthermore, downregulation of PHF8 attenuated the tumorigenicity of ESCC cells in vivo. Taken together, our study revealed the oncogenic features of PHF8 in ESCC, suggesting that PHF8 may be a potential diagnostic marker and therapeutic target for ESCC.

References

[1]  Jemal A, Bray F (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69–90.
[2]  Umar SB, Fleischer DE (2008) Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 5: 517–526.
[3]  Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457–463.
[4]  Meng XY, Zhu ST, Zong Y, Wang YJ, Li P, et al. (2011) Promoter hypermethylation of cyclooxygenase-2 gene in esophageal squamous cell carcinoma. Dis Esophagus 24: 444–449.
[5]  Meng Y, Wang QG, Wang JX, Zhu ST, Jiao Y, et al. (2011) Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma. Dig Dis Sci 56: 3195–3203.
[6]  Mosammaparast N, Shi Y (2010) Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 79: 155–179.
[7]  Pedersen MT, Helin K (2010) Histone demethylases in development and disease. Trends Cell Biol 20: 662–671.
[8]  Rotili D, Mai A (2011) Targeting Histone Demethylases: A New Avenue for the Fight against Cancer. Genes Cancer 2: 663–679.
[9]  Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A, Shimada Y, et al. (2000) Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res 60: 4735–4739.
[10]  Liu W, Tanasa B, Tyurina OV, Zhou TY, Gassmann R, et al. (2010) PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature 466: 508–512.
[11]  Qi HH, Sarkissian M, Hu GQ, Wang Z, Bhattacharjee A, et al. (2010) Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature 466: 503–507.
[12]  Qiu J, Shi G, Jia Y, Li J, Wu M, et al. (2010) The X-linked mental retardation gene PHF8 is a histone demethylase involved in neuronal differentiation. Cell Res 20: 908–918.
[13]  Laumonnier F, Holbert S, Ronce N, Faravelli F, Lenzner S, et al. (2005) Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate. J Med Genet 42: 780–786.
[14]  Yatim A, Benne C, Sobhian B, Laurent-Chabalier S, Deas O, et al. (2012) NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol Cell 48: 445–458.
[15]  Lim HJ, Dimova NV, Tan MK, Sigoillot FD, King RW, et al.. (2013) The G2-M regulator, histone demethylase PHF8, is targeted for degradation by APCcdc20. Mol Cell Biol Published online August 26, 2013.
[16]  Bjorkman M, Ostling P, Harma V, Virtanen J, Mpindi JP, et al. (2012) Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion. Oncogene 31: 3444–3456.
[17]  Jiang X, Sun L, Qiu JJ, Sun X, Li S, et al. (2013) A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia. PLoS One 8: e72335.
[18]  Shi HY, Lv FJ, Zhu ST, Wang QG, Zhang ST (2011) Dual inhibition of 5-LOX and COX-2 suppresses esophageal squamous cell carcinoma. Cancer Lett 309: 19–26.
[19]  Shen H, Laird PW (2013) Interplay between the Cancer Genome and Epigenome. Cell 153: 38–55.
[20]  Zhao SL, Zhu ST, Hao X, Li P, Zhang ST (2011) Effects of DNA methyltransferase 1 inhibition on esophageal squamous cell carcinoma. Dis Esophagus 24: 601–610.
[21]  Zhao Y, Schetter AJ, Yang GB, Nguyen G, Mathe EA, et al. (2013) microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma. Int J Cancer 132: 2901–2909.
[22]  Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6: 838–849.
[23]  Greer EL, Shi Y (2012) Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 13: 343–357.
[24]  Miller PG, Al-Shahrour F, Hartwell KA, Chu LP, Jaras M, et al. (2013) In Vivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling. Cancer Cell 24: 45–58.
[25]  Lv T, Yuan D, Miao X, Lv Y, Zhan P, et al. (2012) Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer. PLoS One 7: e35065.
[26]  Lynch JT, Harris WJ, Somervaille TC (2012) LSD1 inhibition: a therapeutic strategy in cancer? Expert Opin Ther Targets 16: 1239–1249.
[27]  Schenk T, Chen WC, Gollner S, Howell L, Jin L, et al. (2012) Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med 18: 605–611.
[28]  Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, et al. (2010) Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468: 839–843.
[29]  Arteaga MF, Mikesch JH, Qiu J, Christensen J, Helin K, et al. (2013) The Histone Demethylase PHF8 Governs Retinoic Acid Response in Acute Promyelocytic Leukemia. Cancer Cell 23: 376–389.
[30]  Meng XY, Zhu ST, Zhou QZ, Li P, Wang YJ, et al. (2012) Promoter methylation regulates cigarette smoke-stimulated cyclooxygenase-2 expression in esophageal squamous cell carcinoma. J Dig Dis 13: 208–213.
[31]  Qiu JJ, Chu H, Lu X, Jiang X, Dong S (2011) The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia. Oncogene 30: 967–977.

Full-Text

comments powered by Disqus